BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6981667)

  • 1. The effect of T cell growth factor on the cell cycle of primate T cells.
    Brown RL; Griffith RL; Neubauer RH; Rabin H
    J Immunol; 1982 Nov; 129(5):1849-53. PubMed ID: 6981667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.
    Sekaly RP; MacDonald HR; Zaech P; Nabholz M
    J Immunol; 1982 Oct; 129(4):1407-14. PubMed ID: 6980934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the rate of cell cycle progression in quiescent cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.
    Sekaly RP; MacDonald HR; Nabholz M; Smith KA; Cerottini JC
    J Cell Physiol; 1984 Oct; 121(1):159-66. PubMed ID: 6332815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allo-Ia reactive murine T-cell lines. II. Mechanisms of clonal expansion of T cells explored by use of the allo-Ia reactive T cell clones.
    Narimatsu H; Saito K
    J Immunol; 1983 Jul; 131(1):37-44. PubMed ID: 6190916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
    Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV).
    Gallo RC
    Blood Cells; 1981; 7(2):313-29. PubMed ID: 6975142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
    J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.
    Bonnard GD; Yasaka K; Jacobson D
    J Immunol; 1979 Dec; 123(6):2704-8. PubMed ID: 315430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures.
    Gullberg M; Ivars F; Coutinho A; Larsson EL
    J Immunol; 1981 Aug; 127(2):407-11. PubMed ID: 6454723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytohemagglutinin-induced human T-lymphocyte colonies: cellular and T-cell growth factor requirements are the same as for suspension culture growth.
    Ruscetti FW
    Nat Immun Cell Growth Regul; 1983-1984; 3(2):102-12. PubMed ID: 6333587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
    Rabin H; Hopkins RF; Ruscetti FW; Neubauer RH; Brown RL; Kawakami TG
    J Immunol; 1981 Nov; 127(5):1852-6. PubMed ID: 6975300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell growth factor: parameters for production.
    Ruscetti FW; Mier JW; Gallo RC
    J Supramol Struct; 1980; 13(2):229-41. PubMed ID: 6972470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG; Shi Y; Mills GB; Miller RG
    Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. II. Cell cycle dependency of Epo action.
    Tsuda H; Sawada T; Kawakita M; Takatsuki K
    Exp Hematol; 1989 Mar; 17(3):218-22. PubMed ID: 2917620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
    Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
    Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
    Gootenberg JE; Ruscetti FW; Gallo RC
    J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
    Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
    J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of BALB/c-3T3 cells in late G1: commitment to DNA synthesis controlled by somatomedin C.
    Wharton W; Van Wyk JJ; Pledger WJ
    J Cell Physiol; 1981 Apr; 107(1):31-9. PubMed ID: 7194350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.